Advertisement

Topics

Triumvira Immunologics Company Profile

06:53 EDT 15th August 2018 | BioPortfolio

Triumvira is developing an engineered T-cell technology called the T-Cell Antigen Coupler (TAC), developed in the laboratory of Dr. Jonathan Bramson at McMaster University in Hamilton, Ontario, and is designed to activate T-cells through the T-cell receptor complex. In multiple liquid and solid tumor animal models, TAC-T cells outperform CAR-T cells, with markedly improved pharmacodynamic effects and reduced toxicity. The company aims to enter the clinic a year from now, and is focusing its pipeline expansion on solid tumor targets. Not only does the TAC-T platform offer best-in-class potential, but the novel structure provides freedom to operate in a crowded space.


News Articles [14 Associated News Articles listed on BioPortfolio]

Triumvira Immunologics Names Donna Rill Chief Technology Officer

Triumvira Immunologics, an Austin, TX-based biotech, appointed Donna Rill to serve as chief technology officer. Triumvera said Rill will use her technology development and manufacturing experience to ...

Triumvira Immunologics to Present at the 25th BioCentury Future Leaders Conference

Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today announced that it will pres...

Triumvira Immunologics Appoints Scott Smith to Board of Directors

Innovative immuno-therapy company welcomes former President and COO of Celgene Triumvira Immunologics, Inc., a privately held biopharmaceutical company developin...

Triumvira Immunologics Appoints Cynthia Collins to Board of Directors

Innovative immuno-therapy company welcomes a recognized leader in life sciences and therapeutics Triumvira Immunologics, a privately-held biopharmaceutical company deve...

Triumvira Hires Donna Rill as Chief Technology Officer

Brings 30-years of Experience to Company’s Technology Development and Manufacturing Operations Triumvira Immunologics, a privately held biopharmaceutical company deve...

Triumvira Immunologics to Participate in Two Upcoming Conferences: Sachs Immuno-Oncology BD&L and Investment Forum and 2018 BIO International Convention

Triumvira Immunologics, Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple types of cancers, today anno...

Triumvira Expands Management Team with Chief Medical Officer and VP of Finance

Innovative immuno-therapy company welcomes proven leaders in pharma and therapeutics Triumvira Immunologics, a privately held biopharmaceutical company developing ...

Triumvira Immunologics to Present at Two Upcoming Conferences: International Society for Cellular Therapy and Bloom Burton & Co. Healthcare Investor Conference

Triumvira Immunologics, Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple types of cancers, today anno...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Triumvira Immunologics, Inc.

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the...

Triumvira Immunologics

Triumvira is developing an engineered T-cell technology called the T-Cell Antigen Coupler (TAC), developed in the laboratory of Dr. Jonathan Bramson at McMaster University in Hami...

Signature Immunologics

Signature Immunologics produces anti-hapten IgGs for High Performance Immunocytochemistry (HPI), targeting key small molecules in cell physiology, including fast neurotransmitter amino acids and pivot...

Quantum Immunologics, Inc.

Signature Immunologics, Inc.

Nil

More Information about "Triumvira Immunologics" on BioPortfolio

We have published hundreds of Triumvira Immunologics news stories on BioPortfolio along with dozens of Triumvira Immunologics Clinical Trials and PubMed Articles about Triumvira Immunologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Triumvira Immunologics Companies in our database. You can also find out about relevant Triumvira Immunologics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record